Tiziana Life Sciences reports positive preclinical findings for intranasal anti-CD3 therapy in brain aging
Tiziana Life Sciences (US:TLSA) Proactiveinvestors NA·2026-04-01 21:20公司与行业动态 - Tiziana Life Sciences Ltd 为内容发布服务向相关公司支付年度现金报酬 通常最高为 $25,000 [2]